IN2014DE01467A - - Google Patents

Info

Publication number
IN2014DE01467A
IN2014DE01467A IN1467DE2014A IN2014DE01467A IN 2014DE01467 A IN2014DE01467 A IN 2014DE01467A IN 1467DE2014 A IN1467DE2014 A IN 1467DE2014A IN 2014DE01467 A IN2014DE01467 A IN 2014DE01467A
Authority
IN
India
Prior art keywords
hot
melt
temperature
drug
melt extrusion
Prior art date
Application number
Other languages
English (en)
Inventor
Shogo Warashina
Fumie Kusaki
Kazuki Kikuchi
Sakae Obara
Naosuke Maruyama
Original Assignee
Shinetsu Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50842156&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DE01467(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co
Publication of IN2014DE01467A publication Critical patent/IN2014DE01467A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/193Mixed ethers, i.e. ethers with two or more different etherifying groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/20Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B13/00Preparation of cellulose ether-esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/20Compounding polymers with additives, e.g. colouring
    • C08J3/201Pre-melted polymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08Cellulose derivatives
    • C08L1/32Cellulose ether-esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/08Cellulose derivatives
    • C08J2301/32Cellulose ether-esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1467DE2014 2013-06-03 2014-06-03 IN2014DE01467A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013116836 2013-06-03
JP2013246178 2013-11-28

Publications (1)

Publication Number Publication Date
IN2014DE01467A true IN2014DE01467A (enExample) 2015-07-24

Family

ID=50842156

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1467DE2014 IN2014DE01467A (enExample) 2013-06-03 2014-06-03

Country Status (8)

Country Link
US (2) US10646573B2 (enExample)
EP (2) EP2810660B1 (enExample)
JP (2) JP6007322B2 (enExample)
KR (2) KR102228157B1 (enExample)
CN (2) CN105283203B (enExample)
IN (1) IN2014DE01467A (enExample)
PT (2) PT2810660T (enExample)
WO (1) WO2014196519A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10646573B2 (en) 2013-06-03 2020-05-12 Shin-Etsu Chemical Co., Ltd. Composition for hot melt extrusion and method for producing hot melt extrudate by using same
JP6203702B2 (ja) 2014-11-18 2017-09-27 信越化学工業株式会社 ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法
MX2017008077A (es) 2014-12-18 2017-09-28 Merck Sharp & Dohme Composiciones de (s)-n-(3-(6-isopropoxipiridin-3-il)-1h-indazol-5- il)-1-(2-(4-(4-(1-metil-1h-1,2,4-triazol-3-il)fenil)-3,6-dihidrop iridin-1(2h)-il)-2-oxoetil)-3-(metiltio)pirrolidin-3-carboxamida para preparaciones farmaceuticas.
JP6725534B2 (ja) * 2015-05-15 2020-07-22 ダウ グローバル テクノロジーズ エルエルシー 極めて高い分子量及び低い粘度のエステル化セルロースエーテルの生成プロセス
CN107567463A (zh) * 2015-05-15 2018-01-09 陶氏环球技术有限责任公司 制备高分子量酯化纤维素醚的工艺
EP3328899B1 (en) * 2015-07-28 2019-06-19 Dow Global Technologies LLC Process for producing dispersion of esterified cellulose ether
WO2018170062A1 (en) 2017-03-17 2018-09-20 Dow Global Technologies Llc Process for recovering an esterified cellulose ether from a reaction product mixture
WO2018170083A1 (en) 2017-03-17 2018-09-20 Dow Global Technologies Llc Process for recovering an esterified cellulose ether from a reaction product mixture
WO2018170060A1 (en) 2017-03-17 2018-09-20 Dow Global Technologies Llc Process for recovering an esterified cellulose ether from a reaction product mixture
US20180282527A1 (en) * 2017-03-30 2018-10-04 Shin-Etsu Chemical Co., Ltd. Injection molding composition containing hypromellose acetate succinate and method for producing same
CN109078186B (zh) * 2017-06-14 2021-09-03 江苏恒瑞医药股份有限公司 一种胃漂浮组合物及其制备方法
TR201722852A2 (tr) * 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Mesalazi̇ni̇n oral farmasöti̇k kompozi̇syonlari
WO2020131801A1 (en) 2018-12-18 2020-06-25 DDP Specialty Electronic Materials US, Inc. A sustained release composition comprising a hydroxypropyl methylcellulose acetate succinate
JP7050714B2 (ja) * 2019-04-04 2022-04-08 信越化学工業株式会社 腸溶性コーティング用組成物及び固形製剤の製造方法
JP7252882B2 (ja) * 2019-11-01 2023-04-05 信越化学工業株式会社 ヒドロキシプロピルメチルセルロースアセテートサクシネートの製造方法
JP7273691B2 (ja) 2019-11-01 2023-05-15 信越化学工業株式会社 ヒドロキシプロピルメチルセルロースフタレートの製造方法
WO2021118915A1 (en) 2019-12-09 2021-06-17 Nutrition & Biosciences Usa 1, Llc Hydroxypropyl alkyl cellulose acetate succinate heteropolymers
WO2022034232A1 (en) 2020-08-13 2022-02-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
JP7399060B2 (ja) * 2020-10-01 2023-12-15 信越化学工業株式会社 ヒドロキシプロピルメチルセルロースアセテートサクシネートの製造方法
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
CN115581678B (zh) * 2022-11-04 2023-09-12 北京鑫开元医药科技有限公司 一种瑞派替尼片组合物及其制备方法
CN115651085B (zh) * 2022-11-14 2023-11-17 乳源东阳光药业有限公司 一种醋酸羟丙甲纤维素琥珀酸酯的纯化方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852421A (en) 1970-03-23 1974-12-03 Shinetsu Chemical Co Excipient and shaped medicaments prepared therewith
US4226981A (en) 1977-09-28 1980-10-07 Shin-Etsu Chemical Co., Ltd. Ether-ester derivatives of cellulose and their applications
JPS5951562B2 (ja) 1977-10-25 1984-12-14 信越化学工業株式会社 セルロ−スエ−テルの酸性サクシニルおよび脂肪族モノアシル混成エステルの製造方法
US4266981A (en) 1978-03-08 1981-05-12 Purdue Research Corporation Process for recovering and utilizing cellulose using sulfuric acid
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
JPWO2003077827A1 (ja) 2002-03-19 2005-07-14 日本新薬株式会社 医薬固体分散体の製造方法
KR100454394B1 (ko) 2002-03-27 2004-10-26 이원희 맥파검출장치
JP4344914B2 (ja) * 2003-02-28 2009-10-14 信越化学工業株式会社 アルカリ溶解性カルボン酸エステル系セルロース誘導体及び該誘導体からなるフィルム
WO2005115330A2 (en) 2004-05-28 2005-12-08 Pfizer Products Inc. Pharmaceutical compositions with enhanced performance
CA2621800A1 (en) * 2005-09-06 2007-03-15 Astellas Pharma Inc. Fine particles of poorly soluble drug having enteric base material adsorbed on the surface thereof
JP5576922B2 (ja) * 2006-04-20 2014-08-20 信越化学工業株式会社 腸溶性固体分散体を含んでなる固形製剤
JP5052051B2 (ja) * 2006-06-16 2012-10-17 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
JP5070618B2 (ja) * 2006-06-16 2012-11-14 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
US20090093442A1 (en) 2006-10-20 2009-04-09 Lynch Stephanie K Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
WO2009129301A2 (en) 2008-04-15 2009-10-22 Schering Corporation Oral pharmaceutical compositions in a molecular solid dispersion
TWI388324B (zh) 2008-04-15 2013-03-11 Schering Corp 含有泊沙康唑(posaconazole)之高密度組合物及包含該組合物之調配物
EP2927720B1 (en) 2010-02-03 2018-10-17 Tyco Electronics Nederland B.V. Enclosure assembly for a connector, strain relief element, and method
BR112012031667A2 (pt) 2010-06-14 2016-11-08 Dow Global Technologies Llc composição
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
US8591944B2 (en) * 2011-03-08 2013-11-26 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
JP2013116836A (ja) 2011-12-02 2013-06-13 Sharp Corp シリコン端材の再利用方法並びに原料シリコン、多結晶シリコン材料及び多結晶シリコン太陽電池の製造方法
DE102012010430A1 (de) 2012-05-29 2013-12-05 Krohne Ag Durchflussmessgerät
JP6215945B2 (ja) 2012-08-24 2017-10-18 ダウ グローバル テクノロジーズ エルエルシー 新規ヒドロキシアルキルメチルセルロースアセテートサクシネート
US10646573B2 (en) * 2013-06-03 2020-05-12 Shin-Etsu Chemical Co., Ltd. Composition for hot melt extrusion and method for producing hot melt extrudate by using same

Also Published As

Publication number Publication date
KR20140142173A (ko) 2014-12-11
US20160095928A1 (en) 2016-04-07
EP2810660A1 (en) 2014-12-10
US10016508B2 (en) 2018-07-10
CN104208713A (zh) 2014-12-17
US20140357681A1 (en) 2014-12-04
JP2015127316A (ja) 2015-07-09
EP2810660B1 (en) 2017-07-26
PT3006049T (pt) 2018-03-20
JPWO2014196519A1 (ja) 2017-02-23
KR20160015234A (ko) 2016-02-12
JP6007322B2 (ja) 2016-10-12
US10646573B2 (en) 2020-05-12
PT2810660T (pt) 2017-08-16
EP3006049B1 (en) 2018-02-28
CN105283203A (zh) 2016-01-27
CN104208713B (zh) 2018-04-27
CN105283203B (zh) 2018-12-28
JP6126555B2 (ja) 2017-05-10
EP3006049A1 (en) 2016-04-13
EP3006049A4 (en) 2017-02-22
KR101918327B1 (ko) 2018-11-13
WO2014196519A1 (ja) 2014-12-11
KR102228157B1 (ko) 2021-03-17

Similar Documents

Publication Publication Date Title
IN2014DE01467A (enExample)
HUE066810T2 (hu) Stabilizált fluorolefin kompozíciók és eljárás elõállításukra, tárolásukra és felhasználásukra
AU2019268159A1 (en) Systems and methods for synthesizing chemical products, including active pharmaceutical ingredients
EP4449901A3 (en) Capsule for tobacco industry product
IN2014DE02197A (enExample)
HUE038367T2 (hu) Új indazolkarboxamidok, eljárás ezek elõállítására, ezeket tartalmazó gyógyszerkészítmények, valamint ezek alkalmazása gyógyszerkészítmények elõállítására
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
MX2014012527A (es) Dihidrato de un compuesto de benzotiofeno o de una sal del mismo y proceso para producir el mismo.
MX2018005741A (es) Composicion para el cuidado de mascotas.
EP3283470A4 (en) Processes for producing 2,5-furandicarboxylic acid and derivatives thereof and polymers made therefrom
EP2898948A4 (en) GLYCERINE DEHYDRATION CATALYST, METHOD OF MANUFACTURING THEREOF, AND METHOD FOR THE PRODUCTION OF ACROLEINE
EP3315499A4 (en) CRYSTAL OF (6S,9aS)-N-BENZYL-6-[(4-HYDROXYPHENYL)METHYL]- 4,7-DIOXO-8-({6-[3-(PIPERAZIN-1-YL)AZETIDIN-1-YL]PYRIDIN- 2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRAZINO[2,1-c][1,2,4]TRIAZINE-1-CARBOXAMIDE COMPOUND
WO2015019198A3 (en) High potency pancreatin pharmaceutical compositions
HK1251566A1 (zh) 作为hdac1/2抑制剂的呱啶衍生物
IN2013CH02295A (enExample)
HUE039507T2 (hu) Új indol- és pirrolszármazékok, elõállítási eljárásuk és ezeket tartalmazó gyógyszerészeti készítmények
PH12021550413A1 (en) Vitamin d pediatric dosage forms, methods of making and using
IN2014DE03239A (enExample)
SA520411635B1 (ar) A2a مشتق حلقي مدمج كمثبط مستقبل
SG11202105995QA (en) Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof
SMP201500110B (it) Prodotto alimentare ripieno, nonche' metodo di produzione di tale prodotto alimentare
TR201722603A2 (tr) Metformi̇n ve si̇tagli̇pti̇n i̇çeren sicak eri̇tme ekstrüzyonu i̇le gerçekleşti̇ri̇len tablet formülasyonlari
WO2014160143A3 (en) Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders
MX2021003908A (es) Polipeptidos de accion prolongada y metodos para su produccion y administracion.
IL323447A (en) The history of cyclohexanone derivatives, the compositions containing them, and their use as medicines